CHI Advisors’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

CHI Advisors’s Portfolio SYRS Stock Details SYRS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$5.12M	Buy
2023 Q2	$2.42M	Hold
2023 Q1	$2.05M	Buy